To compare surgery with definitive chemoradiotherapy for patients with resectable cervical esophageal squamous cell carcinoma.

Inclusion Criteria:

• Patients with resectable cervical esophageal squamous cell carcinoma (cT1b-T4aN0-3M0);
• Cervical esophageal cancers spreads upwards to involve the hypopharynx and downwards to involve the thoracic esophagus can also be included;
• Aged 18-75 years;
• Without any contraindication of operation;
• Hemoglobin >=90 g/L; Leukocytes >=4.0x10^9/L; Absolute neutrophil count >=1.5x10^9/L; Platelet >=100x10^9/L;Total bilirubin <=1.5 ULN; ALT <=2.5 ULN; AST <=2.5 ULN; Serum creatinine <=1.5 ULN or creatinine clearance rate >=50 mL/min (Cocheroft-Gault);INR <=1.5 ULN; APTT <=1.5 ULN;
• Without other malignancies;
• Expected R0 resection;
• ECOG PS 0-1;
• Volunteered to participate in the study, signed the informed consent form.

Exclusion Criteria:

• Without other malignancies;
• With mental diseases;
• With hemorrhagic disease;
• Inoperable patients;
• Pregnant or lactating women;
• Has a history of allergy to paclitaxel or cisplatin

expected to be shared as an article paper after the trial ends

expected to be shared as an article paper after the trial ends